Loading...
Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH). Statement from NIH and BARDA on the Novavax COVID-19 Vaccine 07/20/2022 11:00 AM EDTThe Centers for Disease Control and Prevention has recommended that Novavaxs COVID-19 vaccine be used as another primary series option for adults in the United States ages 18 years and older.
|
Loading...
Loading...